BioSpace News Archive

The report draws readers’ attention to the key segments and sub-segments of the industry and offers details on the leading regional markets, intensely competitive scenario, leading product and application segments, technology landscape, sales & distribution networks, and key industry statistics.

adyn, the first to create a test designed to prevent birth control side effects, announced today the official launch of its flagship product, The Birth Control Test.

Rising incidences of anxiety disorders, insomnia, & alcohol addiction, increasing investments on research & development, new product launches, increasing awareness for its safe application and various ongoing clinical trials are key factors contributing to high CAGR of Diazepam market during the forecast period.

The report draws readers’ attention to the key segments and sub-segments of the industry and offers details on the leading regional markets, intensely competitive scenario, leading product and application segments, technology landscape, sales & distribution networks, and key industry statistics.

The rapid proliferation of emerging technologies like Artificial Intelligence and Machine Learning to achieve greater efficiency in healthcare services is expected to drive the market demand.

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced its participation in the 2022 H.C. Wainwright Global Investment Conference.

The report draws readers’ attention to the key segments and sub-segments of the industry and offers details on the leading regional markets, intensely competitive scenario, leading product and application segments, technology landscape, sales & distribution networks, and key industry statistics.

Increasing prevalence of breast cancer across the globe, rising government fund for ongoing research on breast cancer, and increasing public awareness about cancer are key factors fueling global market growth

Entitled “Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptinin Combination with Filgrastim in Early Recovery” the study results were presented during the Latebreaker Session on Saturday, May 21, 2022 at the World Congress on Acute Heart Failure 2022 in Madrid by the Principal Investigator Dirk von Lewinski from the Department of Cardiology of the Medical University of Graz, Austria.

The report draws readers’ attention to the key segments and sub-segments of the industry and offers details on the leading regional markets, intensely competitive scenario, leading product and application segments, technology landscape, sales & distribution networks, and key industry statistics.